작성자Functional Protein Engineering Lab (FPEL) 조회수982Date2021-05-06
Byungseop Yang's manuxss-script titled as "Multivalent albumin-FcRn interactions mediate a prominent extension of the serum half-life of a therapeutic protein" was accepted to Molecular Pharmaceutics.
Congratulation!
